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Chikungunya virus (CHIKV) is an emerging human pathogen transmitted by mosquitoes. Like that of other
alphaviruses, CHIKV replication causes general host shutoff, leading to severe cytopathicity in mammalian
cells, and inhibits the ability of infected cells to respond to interferon (IFN). Recent research, however, suggests
that alphaviruses may have additional mechanisms to circumvent the host’s antiviral IFN response. Here we
show that CHIKV replication is resistant to inhibition by interferon once RNA replication has been established
and that CHIKV actively suppresses the antiviral IFN response by preventing IFN-induced gene expression.
Both CHIKV infection and CHIKV replicon RNA replication efficiently blocked STAT1 phosphorylation and/or
nuclear translocation in mammalian cells induced by either type I or type II IFN. Expression of individual
CHIKV nonstructural proteins (nsPs) showed that nsP2 was a potent inhibitor of IFN-induced JAK-STAT
signaling. In addition, mutations in CHIKV-nsP2 (P718S) and Sindbis virus (SINV)-nsP2 (P726S) that render
alphavirus replicons noncytopathic significantly reduced JAK-STAT inhibition. This host shutoff-independent
inhibition of IFN signaling by CHIKV is likely to have an important role in viral pathogenesis.
Chikungunya virus (CHIKV) is a mosquito-borne arthro-
genic member of the Alphavirus genus (family Togaviridae)
causing current epidemics in the Indian Ocean region (25).
The first reported CHIKV outbreak was in 1952 to 1953 in
Tanzania. In the local Makonde language, chikungunya means
“that which bends up” and refers to the body posture of in-
fected individuals who suffer from associated arthralgia (29).
CHIKV is transmitted mainly by Aedes mosquito species and is
endemic in most of Central Africa and Southern Asia (18).
From 2001 onwards, several major outbreaks have occurred
affecting the islands of Mauritius, Madagascar, Mayotte, and
Reunion Island. On Reunion Island, CHIKV affected up to
one-third of the population, and CHIKV-associated deaths
were recorded (25). Due to an acquired mutation in the viral
glycoprotein E1 (39) and the concurrent expanding distribu-
tion of its novel mosquito vector Aedes albopictus, CHIKV is
rapidly spreading to other parts of the world, including Europe
(9). In 2006, mainland India suffered a major outbreak in
which more than 1.4 million individuals were infected, after
which more outbreaks occurred throughout the rest of South-
ern Asia (38). The first outbreak of CHIKV on the European
continent occurred in Italy in 2007 (27). Currently, no licensed
CHIKV vaccine and no effective antiviral treatment are avail-
able.
CHIKV is a plus-strand RNA virus with a genome of almost
12 kb and replicates in the cytoplasm of infected cells within
virus-induced membranous vesicles (17). CHIKV produces
two polyproteins, of which the first encodes nonstructural pro-
teins (nsPs) 1, 2, 3, and 4. The nsP123 precursor and nsP4
function in a complex for viral negative-strand RNA synthesis,
after which sequential processing of nsP123 into its individual
proteins results in positive-strand RNA transcription and the
production of subgenomic RNA (sgRNA). CHIKV nsPs serve
functions needed for viral replication, e.g., methyltransferase
and guanylyltransferase (nsP1), protease and helicase (nsP2),
and RNA-dependent RNA polymerase (nsP4) (37). The sec-
ond, structural polyprotein is translated from this sgRNA and
contains capsid and envelope glycoproteins that constitute the
virus particle (37). In mosquito cells, alphaviruses can replicate
in a persistent manner, whereas alphavirus replication in mam-
malian cells usually results in severe cytopathicity, mainly
caused by a dramatic shutoff of host gene expression, resulting
in the suppression of innate immunity (16).
Cellular sensors, including the cytoplasmic RNA helicase
MDA5, are able to detect alphavirus replication in infected
mammalian cells (4). Downstream signal transduction ulti-
mately leads to interferon regulatory factor 3 (IRF-3) activa-
tion and beta interferon (IFN-) production. After secretion
from the infected cell, IFN- binds to the IFN-/ receptor
IFNAR in an autocrine or paracrine manner to amplify the
signal or to prime uninfected cells to establish an antiviral
state, respectively. Subsequently, the Janus kinases JAK1 and
TYK2 are phosphorylated and, in turn, phosphorylate signal
transducers and activators of transcription 1 and 2 (STAT1 and
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STAT2) (26). Heterodimers of STAT1/STAT2 are then trans-
located in an IRF-9-dependent manner from the cytoplasm
into the nucleus, where they bind IFN-stimulated response
elements (ISRE). STAT1 activation causes cells to produce
and secrete IFN- to further amplify the signal via the same
signaling cascade. In addition, the expression of an array of
antiviral proteins, including protein kinase R (PKR), 2,5-
oligoadenylate synthetase (OAS), and Mx proteins, is then
induced to ultimately clear the infection (26). In addition to
the type I IFNs (IFN-/) expressed by most cells, type II IFN
(IFN-) is also produced early in CHIKV infection, probably
by NK cells (12), to promote the transition from innate to
adaptive immunity. IFN- activates STAT1 via binding to the
IFN- receptor, upon which the latter in the form of ho-
modimers translocates to the nucleus, where it binds gamma-
activating sequence (GAS) elements to transactivate antiviral
gene expression (26).
Given the potency of IFNs in fighting viral infection, many
viruses have evolved specific strategies to counteract or evade
the antiviral IFN response (26). While alphaviruses are known
to cause dramatic host protein synthesis shutoff (16), recent
research has shown that this alone is not sufficient to ensure
productive infection and that the IFN response is also antag-
onized in a more direct manner (35). Whether or not CHIKV
counteracts the IFN response is unknown; however, it is clear
that robust IFNAR-dependent type I IFN signaling is required
in order to limit CHIKV replication in animals (5, 32). IFN-
was recently shown to inhibit CHIKV replication in mice if
given before infection, but not when given 3 days after infec-
tion (12).
In this paper, we show that CHIKV replication is resistant to
IFN treatment and inhibits IFN-induced JAK-STAT signaling
and downstream gene transcription independently of host
shutoff. We also show for the first time that alphavirus nsP2
alone is sufficient for JAK-STAT inhibition. A P726S substi-
tution in a conserved region of Sindbis virus (SINV) nsP2 was
previously reported to reduce SINV cytopathicity (8). Here we
show that this substitution and the corresponding P718S sub-
stitution in CHIKV reversed the ability of CHIKV and SINV
replicons to block the JAK-STAT pathway.
MATERIALS AND METHODS
Cells and virus. African green monkey kidney (Vero) and baby hamster kidney
(BHK-21J) cells were cultured in Dulbecco’s modified Eagle medium (DMEM;
Invitrogen) supplemented with 10% fetal bovine serum (FBS; Invitrogen) at
37°C in an atmosphere with 5% CO2 in tissue culture flasks (Greiner). Chikun-
gunya virus isolate 06113879 (Mauritius strain) was obtained from the Victorian
Infectious Diseases Reference Laboratory (VIDRL) and was supplied via
Queensland Health Forensic and Scientific Services (QHFSS). The isolate was
titrated on Vero cells via plaque assay.
Construction of alphavirus replicons and expression plasmids. A CHIKV
strain 37997 replicon (CHIKrep-EGFP) (see Fig. 4A) expressing EGFP was
constructed by removing the structural genes from CHIKV infectious clone
5-pCHIKic (40) and inserting enhanced green fluorescent protein (EGFP).
Next, a firefly luciferase (Fluc) gene was generated by PCR (Phusion DNA
polymerase; Finnzymes) from pGL3 (Promega) using primers AscI-Luc-F and
BssHII-Luc-R and was cloned into CHIKrep-EGFP, in frame and upstream of
the EGFP gene, to generate CHIKrep-FlucEGFP (see Fig. 1C). The red fluo-
rescent marker gene mCherry (33) was amplified by PCR using primers AscI-
mCherry-F and EcoRI-mCherry-R and was cloned into CHIKrep-EGFP in place
of EGFP to generate CHIKrep-mCherry (see Fig. 5A). A puromycin acetyltrans-
ferase gene fused to the foot-and-mouth disease virus (FMDV) 2A autoprotease
was generated by PCR from repPAC-Gal (21) using primers MluI-PAC2A-F
and -R and was cloned into CHIKrep-EGFP in place of EGFP to generate
CHIKrep-pac2AEGFP (see Fig. 6A). An MluI fragment from CHIKrep-
pac2AEGFP was subcloned into pBluescript and was reinserted after nsP2 was
mutated by QuikChange PCR using primers CHIK-nsP2-P718S-F and -R, gen-
erating CHIKrep-pac2AEGFP-nsP2m. A cytopathic, “wild-type” Sindbis virus
replicon was generated from the noncytopathic replicon SINrepGFP (pHY213;
pToto1101 derivative) by mutating the nsP2 serine at position 726 into a proline
with primers SINnsP2-726P-V426 and SINnsP2-726P-V427 to generate
SINrepGFP-wt (see Fig. 6A). Individual CHIKV nsPs were PCR amplified from
CHIKrep-EGFP using the AttB1 and AttB2 primers listed (Table 1) and were
cloned into expression plasmids downstream of a cytomegalovirus (CMV) im-
mediate-early promoter (see Fig. 6A) via traditional cloning or Gateway tech-
nology using pDONR207 and pcDNA-DEST40 (Invitrogen). The mCherry gene
was fused to the FMDV 2A autoprotease using PCR with primers EcoRI-
mCherry-F and EcoRI-2A-mCherry-R and was cloned as an EcoRI fragment in
frame and upstream of CHIKV nsPs for live visualization of transfected cells (see
Fig. 5A). Autocleavage of the red fluorescent mCherry2A protein from the nsPs
results in the expression of CHIKV nsP1 to nsP4 with nearly authentic N termini
to retain biological activity. All constructs were verified by sequencing (Eurofins
MWG Operon, Germany).
IFN sensitivity assay. (i) CHIKV. For IFN pretreatment, Vero cells grown in
24-well plates were treated with various doses of IFN- (I-4276; Sigma), IFN-
(I-4151; Sigma), and IFN- (I-1520; Sigma) for 6 h. The cells were washed and
infected with CHIKV at a multiplicity of infection (MOI) of 1 PFU per cell.
Three hours after viral absorption, the cells were washed; then they were incu-
bated for an additional 21 h. For IFN posttreatment, Vero cells were infected
with CHIKV at an MOI of 1 PFU/cell. Four hours after viral absorption, cells
were treated with various doses of IFN as indicated (Fig. 1) and were left for an
additional 21 h. The supernatants were collected, and viral titers were deter-
mined by plaque assays on Vero cells.
(ii) CHIKV replicon. In vitro-transcribed, capped CHIKrep-FlucEGFP repli-
con RNA (400 ng/well) was transfected into Vero cells in 96-well plates by using
Lipofectamine 2000 (Invitrogen) and Opti-MEM medium (Invitrogen) accord-
ing to the manufacturer’s recommendations. The transfection mixture was re-
moved after 4 h of incubation and was replaced with DMEM plus 10% FBS.
Directly after transfection (0 h posttransfection [p.t.]) or 24 h p.t., type I IFNs
(IFN- and IFN-; Calbiochem, Nottingham, United Kingdom) and type II IFN
(IFN-; AbD Serotec, Du¨sseldorf, Germany) were added to the wells in increas-
ing concentrations. Two days after transfection, cells were lysed in 100 l passive
lysis buffer (Promega Benelux, Leiden, Netherlands), and luciferase expression
was measured on a Fluostar Optima microplate reader (BMG Labtech, Ger-
many) using D-luciferin (Synchem OHG, Germany) as a substrate basically as
described previously (14).
IFN reporter assay. Vero cells grown in 24-well plates were cotransfected with
40 ng pRL-TK (Promega) plasmid DNA expressing Renilla luciferase (Rluc) and
with 200 ng of either the IFN-/-responsive (ISRE) firefly luciferase (Fluc)
reporter plasmid p(9–27)4th (39)Lucter or the IFN--responsive (GAS) lucif-
erase reporter plasmid p(IRF-1*GAS)6tk (39)Lucter (15) by using the Gene-
jammer (Stratagene) transfection reagent. Briefly, at 24 h p.t., cells were infected
with CHIKV at an MOI of 5 PFU/cell. At 4, 8, and 12 h postinfection (p.i.), cells
were treated with 1,000 IU of IFN- (Intron A Redipen) per ml or 100 ng of
IFN- (BD Pharmingen) per ml for 6 h and were then assayed for Fluc and Rluc
activities using the Dual luciferase reporter assay system (Promega) as described
previously (22).
Real-time RT-PCR. Vero cells grown in 24-well plates were infected with
CHIKV at an MOI of 5 PFU/cell. Healthy or infected cells were subsequently
incubated at 4, 8, or 12 h p.i. with 1,000 IU of IFN- (Intron A Redipen) per ml
or 100 ng of IFN- (BD Pharmingen) per ml for 10 h. Total RNA was purified
using Trizol reagent (Invitrogen), and real-time reverse transcription-PCR (real-
time RT-PCR) was carried out on a Rotor-Gene 3000 PCR machine (Corbett
Research) using Superscript III (Invitrogen) and SYBR green (Invitrogen) ba-
sically as described previously (12). Primers for amplification of OAS2 transcripts
were HuOAS2-F and -R, and primers for the housekeeping gene RPL13A (24)
were HuRPL13A-F and -R. Each sample was analyzed in duplicate and normal-
ized to RPL13A mRNA levels. OAS2 mRNA transcription levels were expressed
relative to levels in mock-infected, IFN-treated samples.
Immunofluorescence and Western blotting. (i) CHIKV virus. Vero cells grown
on glass coverslips in 24-well plates were infected with CHIKV at an MOI of 1
PFU/cell. Twenty-four hours after infection, cells were treated with 1,000 IU/ml
of IFN- (I-4276; Sigma) or 50 ng/ml of IFN- (I-1520; Sigma) for 30 min at
37°C. Cells were fixed in 4% formaldehyde in phosphate-buffered saline (PBS)
for 10 min at room temperature, permeabilized with ice-cold acetone-methanol
(1:1) for 30 min at 20°C, and stained sequentially with cross-reacting mono-
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clonal antibodies specific for CHIKV envelope protein and with polyclonal
antibodies against STAT1 (SC-345; SantaCruz Biotechnology, Santa Cruz, CA)
or STAT2 (SC-476; Santa Cruz) at concentrations of 1 g/ml essentially as
described by the manufacturer. Secondary antibodies (GaM-AF546 and GaR-
AF488) were obtained from Invitrogen, and nuclei were stained with 4,6-
diamidino-2-phenylindole (DAPI). Microscopy was performed using a Zeiss
LSM 510 Meta confocal microscope. For Western blot analysis, Vero cells in
6-well plates were infected with CHIKV at an MOI of 1 PFU/cell. Twenty-four
hours p.i., cells were either treated with IFN- (I-4276; Sigma) or IFN- (I-1520;
Sigma) for 30 min or left untreated as indicated (see Fig. 3). Western blotting was
performed on Vero cell lysates as described previously (22) using antibodies
against phosphorylated STAT1 (pSTAT1) (Pharmingen, San Diego, CA),
STAT1 (SC-345; Santa Cruz), and tubulin (T2200; Sigma), and analysis was
performed with an Odyssey infrared imaging system (LI-COR Biosciences, Lin-
coln, NE).
(ii) Replicons and single nsPs. Vero cells grown in 96-well plates were trans-
fected with capped, in vitro-transcribed CHIKrep-EGFP, CHIKrep-mCherry,
CHIKrep-pac2AEGFP, or CHIKrep-pac2AEGFP-nsP2m replicon RNA, one of
the four pCMV-nsP constructs, or the SINrepGFP construct (400 ng of RNA or
DNA per well) using Lipofectamine 2000 (Invitrogen). Twenty-four hours later,
cells were treated for 30 min with 100 IU IFN- (Calbiochem), 2.5 ng IFN-
(Calbiochem), or 1 ng IFN- (AbD Serotec) per well (100 l). For the host
shutoff experiment, cells were transfected with the CHIKrep-EGFP replicon in
normal medium or medium containing 0.5 g/ml cycloheximide. Twelve hours
p.t., cells received a similar IFN- treatment. Cells were fixed with 4% paraform-
aldehyde in PBS and were permeabilized with 0.1% sodium dodecyl sulfate
(SDS) in PBS to retain EGFP and/or mCherry fluorescence. Nuclei were stained
with Hoechst 3342. STAT1 nuclear translocation was visualized either with an
anti-pSTAT1 primary antibody (phospho-Tyr701; SAB Signalway Antibody,
Pearland, TX) and the secondary antibody GaR-rhodamine (Nordic Immunol-
ogy, Tilburg, Netherlands) or GaR-AF488 (Molecular Probes, Leiden, Nether-
lands) or with an anti-STAT1 primary antibody (SC-417; Santa Cruz) and the
secondary antibody GaM-AF546 (Molecular Probes), using an Olympus IX71
inverted microscope with an X-Cite 120 series lamp.
RESULTS
CHIKV replication confers resistance to type I/II IFN treat-
ment. Since an intact IFN response is a requirement for lim-
iting CHIKV infection in animals (5), we first investigated to
what degree CHIKV replication could be inhibited in cells by
(pre)treatment with type I and type II IFNs. Vero cells have an
intact IFN signaling pathway and respond to IFN treatment;
however, they cannot produce IFN (7) and thus lack the au-
tocrine IFN amplification loop. These characteristics allow ac-
curate measurement of the effects of different, exogenous IFNs
on viral RNA amplification and virus production. When cells
were primed for 6 h with IFN prior to virus infection, CHIKV
production was decreased in an IFN concentration-dependent
manner (Fig. 1A). IFN- was most effective, followed by IFN-
and IFN-. Although pretreatment with 10,000 U/ml of IFN-
could reduce virus production approximately 25-fold (from
8.1  108 to 6.7  106 PFU/ml), viral titers were not reduced
further than 6.7  107 PFU/ml, indicating that CHIKV was
rather insensitive to IFN pretreatment under the experimental
conditions used and still replicated to relatively high titers.
When IFN was applied 4 h p.i., viral titers were not signifi-
cantly decreased (maximum reduction from 1  108 to 7.7 
107 PFU/ml) (Fig. 1B), indicating that virus production was not
greatly affected by high concentrations of IFN when IFN was
added after the establishment of infection.
Next, the effect of IFN treatment on CHIKV RNA replica-
tion, independently of virus production and/or secondary in-
fection, was tested. A CHIKV replicon was constructed in
which the structural genes were replaced by a firefly luciferase
(Fluc)-enhanced green fluorescent protein (EGFP) fusion
gene (CHIKrep-FlucEGFP [Fig. 1C]). In this way, transfected
cells could be visualized by fluorescence microscopy and rep-
lication measured by luminometry. In vitro-transcribed, capped
CHIKrep-FlucEGFP replicon RNA was transfected into Vero
cells. Directly after transfection or 24 h posttransfection (p.t.),
TABLE 1. Oligonucleotides used in this study
Name Sequence (5–3)a
AscI-Luc-F TTGGGCGCGCCATGGAAGACGCCAAAAACATAA
BssHII-Luc-R TTGTGCGCGCTCCACGGCGATCTTTCCGCC
MluI-PAC2A-F TTGGACGCGTCATGACCGAGTACAAGCCCACG
MluI-PAC2A-R TTGTACGCGTTCGGGCCCTGGGTTGGACTCG
AscI-mCherry-F CGGGCGCGCCACCATGGTGAGCAAGGGCGAGGAG
EcoRI-mCherry-R CGGAATTCCTTGTACAGCTCGTCCATG
CHIK-nsP2-P718S-F GCTCAAGTCGGGTGGTTCATTACTG
CHIK-nsP2-P718S-R CCACCCGACTTGAGCAGTCTCAGGG
SINnsP2-726P-V426 CTGAATTGTTTAAACCCAGGAGGCACCCTC
SINnsP2-726P-V427 GAGGGTGCCTCCTGGGTTTAAACAATTCAG
attB1-CHIK-nsP1 GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGAATTCACCATGGATCCCGTGTACGTGG
attB1-CHIK-nsP2 GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGAATTCACCATGGGAATAATTGAAACTCCAAGAG
attB1-CHIK-nsP3 GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGAATTCACCATGGCACCGTCGTACCGGGTT
attB1-CHIK-nsP4 GGGGACAAGTTTGTACAAAAAAGCAGGCTTAGAATTCACCATGTACATATTCTCATCTGACACC
attB2-CHIK-nsP1 GGGGACCACTTTGTACAAGAAAGCTGGGTACTATGCCCCAGCTCTGTCTTC
attB2-CHIK-nsP2 GGGGACCACTTTGTACAAGAAAGCTGGGTACTAGCACCCTGCTCGGGTGG
attB2-CHIK-nsP3 GGGGACCACTTTGTACAAGAAAGCTGGGTACTACCCACCTGCCCTATCTAG
attB2-CHIK-nsP4 GGGGACCACTTTGTACAAGAAAGCTGGGTACTATTTAGGACCACCGTACAG
EcoRI-mCherry-F CGGAATTCACCATGGTGAGCAAGGGCGAGGAG
EcoRI-2A-mCherry-R CGGAATTCGGGCCCTGGGTTGGACTCGACGTCGCCGGCCAACTTGAGCAGGTCAAAGTTAACCTT
GTACAGCTCGTCCATG
HuOAS2-F CGGTGTATGCCTGGGAACAGG
HuOAS2-R GGGTCAACTGGATCCAAGATTAC
HuRPL13A-F CATCGTGGCTAAACAGGTACTG
HuRPL13A-R CGCACGACCTTGAGGGCAGC
a Restriction sites are italicized, start codons are underlined, and mutations are shown in boldface.
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type I/II IFNs were added to the wells in increasing concen-
trations, and luciferase expression was measured 2 days after
transfection. In results similar to those obtained with CHIKV
infection, when IFN was added directly after RNA transfection
(pretreatment), CHIKV replication was negatively affected in
a concentration-dependent manner (Fig. 1D). In the concen-
trations used, IFN- was most effective (10% of transgene
expression retained), followed by IFN- and IFN-. This is
similar to what was reported for SINV, another Old World
alphavirus (41). When IFN was added 24 h p.t., however, Fluc
expression could not be reduced further than approximately
50%, even with the highest IFN concentrations (Fig. 1E). Col-
lectively, these results suggest that CHIKV is insensitive to
IFN once viral RNA replication has been established.
CHIKV infection inhibits type I/II IFN signaling. Since
CHIKV replication is partially sensitive to the priming of cells
with type I IFNs (and to a lesser extent with type II IFN) but
is largely resistant to IFN treatment after viral RNA replica-
tion is well under way, it is likely that CHIKV blocks down-
stream IFN signaling and expression of IFN-stimulated genes
(ISGs) with antiviral activity. To test this hypothesis, the effect
of CHIKV RNA replication on downstream IFN-induced gene
transcription was investigated. Vero cells were transfected with
type I IFN-responsive (ISRE) or type II IFN-responsive
(GAS) Fluc reporter plasmids and were subsequently infected
with CHIKV. Fluc expression was induced by stimulation with
type I/II IFNs at 4, 8, and 12 hpi and was normalized to Renilla
luciferase (Rluc) activity expressed from a constitutive pro-
moter on a cotransfected pRL-TK plasmid (Fig. 2A and B).
Rluc activity decreased approximately 1.5-fold, 2.5-fold, and
4-fold at 4, 8, and 12 hpi, respectively, compared to that in
mock-infected cells (not shown), indicating that CHIKV infec-
tion resulted in some host shutoff within this time frame. How-
ever, the inhibition by CHIKV of IFN-stimulated gene tran-
scription was more pronounced. Relative Fluc expression from
the responsive element ISRE or GAS (normalized to Rluc
expression) in response to treatment with IFN- (Fig. 2A) or
IFN- (Fig. 2B), respectively, was substantially inhibited in
Vero cells infected with CHIKV. This inhibition was apparent
at 4 hpi (2-fold) and 8 hpi (5 to 8-fold) and was essentially
100% at 12 hpi (Fig. 2A and B). In the absence of CHIKV
infection, a 	7-fold or 58-fold induction of normalized Fluc
expression in response to treatment with IFN- (Fig. 2A) or
IFN- (Fig. 2B), respectively, was observed. These results
clearly indicated that CHIKV infection efficiently blocks IFN
signaling beyond the inhibition mediated by host shutoff.
To illustrate that CHIKV infection also inhibited the induc-
tion of ISG expression, an RT-PCR assay was used to monitor
the expression of 2-5-oligoadenylate synthetase 2 (OAS2)
transcripts. As expected (31), large increases in OAS mRNA
levels were seen in Vero cells after treatment with IFN- or
IFN- (Fig. 2C and D, first two bars). However, in cells in-
fected with CHIKV and treated with type I and II IFNs at
various time points p.i., OAS mRNA levels were substantially
reduced relative to levels of the housekeeping gene RPL13A
(Fig. 2C and D). These results demonstrated that CHIKV
infection efficiently blocks ISG expression beyond that medi-
ated by host shutoff.
CHIKV infection and CHIKV replicon RNA replication
block type I/II IFN-induced STAT1 nuclear translocation. In
order to investigate whether CHIKV could block IFN signaling
by specifically interfering with the JAK-STAT pathway, Vero
cells were infected with CHIKV at an MOI of 1 PFU/cell and
were subsequently induced with type I IFN. Induction with
FIG. 1. Resistance of CHIKV to type I/II IFN treatment. (A and
B) Sensitivity of CHIKV infection to IFN treatment. IFNs were added
as indicated to CHIKV-infected Vero cells 6 h prior to infection (A) or
4 h p.i. (B). Supernatants were collected 24 h p.i., and virus titers were
determined by plaque assays. Error bars represent standard deviations
of duplicates. (C) Schematic representation of the CHIKrep-Flu-
cEGFP replicon expressing an Fluc-EGFP fusion protein. (D and E)
Sensitivity of the replication of CHIKV replicon RNA to IFN treat-
ment. Different concentrations of IFNs were added to CHIKV repli-
con-transfected Vero cells in 96-well plates directly posttransfection
(0 h p.t.) (D) or 24 h p.t. (E), and Fluc activity was measured 48 h p.t.
Concentrations of IFN- are expressed in international units (IU) per
ml, and IFN-/ concentrations are expressed in ng per ml. Error bars
represent standard deviations.
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type I IFNs should result in STAT1/STAT2 phosphorylation/
heterodimerization and subsequent nuclear translocation. As
expected, STAT1 in normal Vero cells was localized in the
cytoplasm but translocated to the nucleus upon induction with
type I IFN (Fig. 3A). In contrast, when cells were infected with
CHIKV 12 h prior to IFN induction, STAT1 nuclear translo-
cation was completely blocked (Fig. 3A). The same result was
obtained for STAT2 (Fig. 3B). Similarly, type II IFN stimula-
tion should lead to STAT1 phosphorylation/homodimerization
and nuclear translocation in normal Vero cells, and this was
indeed observed in uninfected cells (Fig. 3C). Again, CHIKV
infection effectively blocked STAT1 nuclear translocation (Fig.
3C). Taken together, these results indicate that CHIKV infec-
tion blocks both type I and type II IFN-induced JAK-STAT
signaling.
It is well known that alphavirus replication leads to host
protein synthesis shutoff (16). However, based on the immu-
nofluorescence detection of similar levels of endogenous
STAT1 and STAT2 in infected and uninfected cells (Fig. 3A to
C), it is unlikely that CHIKV infection depletes/degrades
STAT1/2 proteins. To confirm that the absence of nuclear
phospho-STAT1 in cells infected with CHIKV was not the
result of depletion of STAT1 protein, Western blotting was
performed to detect endogenous STAT1. It is apparent that
cells infected with CHIKV (Fig. 3D, lane 2) have levels of
endogenous STAT1 similar to those in uninfected cells (Fig.
3D, lane 5), suggesting that CHIKV does not degrade endog-
enous STAT1 but may act via the inhibition of STAT1 phos-
phorylation and/or nuclear translocation. As expected, STAT1
was highly upregulated by IFN induction in uninfected cells,
likely through signaling via the JAK-STAT pathway (22). In
contrast, this was not the case in CHIKV-infected cells, sug-
gesting that CHIKV also blocks the IFN-induced upregulation
of STAT1. Importantly, Western blot analysis performed with
antibodies against phospho-STAT1 showed that CHIKV infec-
tion causes a major reduction in the amount of phospho-
STAT1 in induced cells (Fig. 3D, lanes 3 and 4) compared to
that in IFN-induced, uninfected cells (Fig. 3D, lanes 6 and 7).
These data support the observations from the immunofluores-
cence experiments and indicate that CHIKV infection inhibits
STAT phosphorylation.
Some so-called New World alphaviruses need expression of
their capsid gene to modulate the IFN response (1). CHIKV is
an Old World alphavirus and therefore is not expected to need
capsid expression for the suppression of IFN signaling. To
determine whether RNA replication and expression of CHIKV
nsPs are sufficient to block the JAK-STAT pathway, a CHIKV
replicon in which the structural genes were deleted and re-
placed by EGFP was constructed (CHIKrep-EGFP [Fig. 4A]).
In vitro-transcribed CHIKrep-EGFP RNA was transfected into
Vero cells, and the cells were then stimulated with type I and
type II IFNs 24 h p.t. As expected, in untransfected cells,
phospho-STAT1 was found in the nuclei of Vero cells after 30
min of induction with IFN-, and this process occurred even
more efficiently with IFN- or IFN- (Fig. 4B). In contrast,
however, cells transfected with CHIKrep-EGFP (green; ex-
pressing EGFP) and induced with IFN- or IFN- lacked
nuclear STAT1 (Fig. 4C, arrowheads), indicating that CHIKV
replication blocks type I and type II IFN-induced STAT1 phos-
phorylation and/or nuclear translocation.
There is a possibility that the lack of nuclear STAT1 trans-
location in replicon cells could still be due to host shutoff
resulting from CHIKV replicon RNA replication, although
Fig. 3D showed that endogenous STAT1 levels were not de-
creased by CHIKV infection. Nevertheless, to rule out this
possibility, cells were treated with cycloheximide to inhibit
translation. This method of pharmacologically induced host
cell protein synthesis shutoff was recently used in experiments
with Venezuelan equine encephalitis virus (VEEV) to show
that JAK-STAT signaling was blocked by VEEV and not by
host shutoff (35). As expected, STAT1 fluorescence in control
cells not treated with cycloheximide was cytoplasmic, with no
apparent difference in localization or fluorescence intensity
between untransfected cells and green CHIKV replicon-trans-
fected cells (Fig. 4D, top row). After IFN- treatment, STAT1
was translocated into the nucleus in all cells except those ex-
FIG. 2. Inhibition of type I/II IFN signaling and ISG induction by
CHIKV infection. (A and B) Vero cells were transfected with a
pRL-TK plasmid expressing Rluc and either a type I IFN-responsive
(ISRE) or a type II IFN-responsive (GAS) Fluc reporter plasmid. At
24 h p.t., cells were infected with CHIKV at an MOI of 5 PFU/ml. At
4, 8, and 12 h p.i., cells were treated with IFN- at 1,000 IU/ml (A) or
with IFN- at 100 ng/ml (B) for 6 h; then they were assayed for Fluc
and Rluc activities. Activities in mock-infected (uninfected) cells with/
without IFN induction were also measured. Fluc values were divided
by Rluc readings to compensate for virus-induced downregulation of
transcription/translation and were expressed relative to values for
mock-infected, IFN-treated samples. Average values from triplicate
samples are shown. Error bars represent standard deviations. (C and
D) Vero cells, either healthy or infected with CHIKV for 4, 8, or 12 h,
were incubated with 1,000 IU of IFN- (C) or 100 ng of IFN- (D) per
ml for 10 h. Real-time RT-PCR values for the IFN-stimulated gene
OAS2 were normalized to those for the housekeeping gene RPL13A.
OAS2 mRNA transcription levels were expressed relative to those of
mock-infected, IFN-treated samples. Average values from duplicate
samples are shown. Error bars represent standard deviations.
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pressing the CHIKV replicon (Fig. 4D, open arrowheads). In
cells treated with cycloheximide, CHIKV replicon-encoded
EGFP was absent due to effective inhibition of protein synthe-
sis (Fig. 4D, bottom). However, STAT1 nuclear translocation
upon IFN- induction was still clearly apparent, despite effec-
tive inhibition of translation by cycloheximide (Fig. 4D, bot-
tom). Taken together, these experiments clearly show that
CHIKV infection and the replication of CHIKV replicon RNA
efficiently inhibit IFN-stimulated JAK-STAT signaling inde-
pendently of host shutoff.
CHIKV nsP2 inhibits IFN-induced STAT1 nuclear translo-
cation. Since the CHIKV replicon could efficiently inhibit
JAK-STAT signaling, the next question was whether any of the
CHIKV nsPs could be found to be responsible for this activity.
Previous reports suggested that alphavirus nsP2 may be an
important modulator of the IFN response (3, 11); however,
direct inhibition of the JAK-STAT pathway by an individual
alphaviral nsP2 has not been reported.
In order to identify the CHIKV-encoded protein responsible
for blocking STAT1 nuclear translocation, Vero cells were
transfected with plasmids expressing individual nonstructural
proteins fused to self-cleaving mCherry2A; as a control, cells
were transfected with a CHIKV replicon expressing mCherry
(CHIKrep-mCherry) (Fig. 5A). Two days p.t., cells were incu-
bated with IFN-, and nuclear localization of phospho-STAT1
was visualized using anti-pSTAT1 antibodies (note that
pSTAT1 appears green in these images). IFN- induction of
transfected Vero cells showed that STAT1 efficiently translo-
cated to the nucleus in cells expressing nsP1, nsP3, or nsP4
(Fig. 5B, solid arrowheads). Only very few cells were found to
lack nuclear phospho-STAT1 (Fig. 5B, open arrowheads), sug-
gesting that nsP1, -3, and -4 were not capable of efficiently
blocking STAT1 nuclear translocation. In sharp contrast, how-
ever, STAT1 nuclear translocation was absent in the vast ma-
jority of cells expressing nsP2 (Fig. 5B, nsP2, open arrowheads)
and the positive control CHIKrep-mCherry (Fig. 5C, open
arrowheads). In the few nsP2-expressing cells that did display
nuclear pSTAT1, the fluorescence intensity was much lower
than that in untransfected cells (Fig. 5B, nsP2, solid arrow-
heads). As expected, the CHIKrep-mCherry-transfected cells
also showed no nuclear translocation after IFN- treatment
(Fig. 5C, open arrowheads).
These results clearly indicate that individually expressed
CHIKV nsP2 is capable of inhibiting JAK-STAT signaling.
Mutation of a conserved proline in the C terminus of nsP2
abolishes the inhibitory effect of CHIKV and SINV replicons
on JAK-STAT signaling. Mutations in alphavirus nsP2 can
have significant effects on the IFN response (3, 11). For exam-
ple, a mutation of a conserved proline (Fig. 6B) at position 726
in SINV was previously shown to result in noncytopathic RNA
replication (8) and reduced viral titers associated with higher
IFN production (11). We hypothesized that this mutation
could render the replicon unable to block JAK-STAT signal-
FIG. 3. (A to C) CHIKV infection blocks STAT1/STAT2 nuclear
translocation without depleting endogenous STAT1 levels. Vero cells
were infected by CHIKV and were treated with IFN- (A and B) or
IFN- (C) for 30 min. Cells were fixed and stained with monoclonal
antibodies specific for CHIKV envelope protein and STAT1 (A and C)
or STAT2 (B). (C) Block in nuclear translocation of STAT1 in CHIKV
infection in response to treatment with IFN-. Arrowheads indicate
cells negatively infected with CHIKV but with nuclear STAT1/2.
(D) CHIKV infection blocks STAT1 phosphorylation in Vero cells in
response to IFN treatment. pSTAT1, STAT1, and tubulin were de-
tected by Western blotting in CHIKV-infected or mock-infected Vero
cells that were either left untreated or induced with type I or type II
IFNs. Lane 1, protein size marker (in kilodaltons).
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ing. This possibility was investigated by transfecting Vero cells
with cytopathic “wild-type” SINrepGFP-wt (with proline re-
stored at position 726) and the noncytopathic SINV replicon
SINrepGFP (containing the P726S mutation in nsP2) (Fig.
6A). Transfected cells were induced 24 h p.t. with IFN- for 30
min and were stained with phospho-STAT1 antibodies as be-
fore. According to the hypothesis, the cytopathic “wild-type”
SIN replicon was able to effectively block STAT1 nuclear
translocation, whereas the noncytopathic SIN replicon with the
nsP2 P726S mutation (8) was not (Fig. 6C).
We then investigated for CHIKV whether an analogous
mutation of the conserved proline in CHIKV nsP2 at posi-
tion 718 (Fig. 6B) could also be linked to a reduced ability
to block JAK-STAT signaling. A puromycin-selectable
CHIKV replicon designated CHIKrep-pac2AEGFP (Fig.
6A) and the same construct with a nsP2 P718S mutation
FIG. 4. A CHIKV replicon efficiently inhibits type I/II IFN-induced JAK-STAT signaling independently of host shutoff. (A) Schematic
representation of CHIKrepEGFP, expressing EGFP. (B) pSTAT1 nuclear translocation in Vero cells upon induction with type I and type II IFNs.
(C) A CHIKV replicon blocks pSTAT1 nuclear translocation upon type I/II IFN induction. Vero cells were immunostained with an anti-pSTAT1
antibody 24 h p.t. (D) CHIKV RNA replication, but not translational shutoff, blocks STAT1 nuclear translocation. Vero cells were transfected with
CHIKrep-EGFP replicon RNA in the absence or presence of cycloheximide (Chx). Cells were induced for 30 min with IFN- at 12 h p.t. and were
stained with an anti-STAT1 antibody. Open arrowheads indicate CHIKV replicon-positive cells lacking nuclear STAT1.
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(CHIKrep-pac2AEGFP-nsP2m) were constructed and tested
for their abilities to block the JAK-STAT pathway in transient
transfection experiments. The replication efficiency in Vero
cells of CHIKrep-pac2AEGFPnsP2m (5 to 10 EGFP-express-
ing cells per well in a 96-well plate) was severely reduced in
comparison to that of CHIKrep-pac2AEGFP (10% EGFP-
expressing cells). In contrast, the replication efficiency in BHK-
21J cells of CHIKrep-pac2AEGFP-nsP2m compared to
CHIKrep-pac2AEGFP was only slightly reduced (10% ver-
sus20% EGFP-expressing cells), but with notable differences
in the induction of cytopathic effect (CPE). BHK-21J cells
transfected with CHIKrep-pac2AEGFP-nsP2m retained nor-
mal cell morphology, in contrast to cells transfected with
CHIKrep-pac2AEGFP, which lost adherence and showed cell
rounding 48 h p.t. (data not shown).
In order to investigate the effect of the CHIKV nsP2 P718S
mutation on JAK-STAT signaling, Vero cells transfected with
CHIKrep-pac2AEGFP or CHIKrep-pac2AEGFP-nsP2m were
induced with IFN- at 24 h p.t. and were stained with an
anti-STAT1 antibody as before. In results similar to those
obtained with SINV, the CHIKV replicon expressing nsP2-
P718S was indeed unable of blocking IFN--induced STAT1
nuclear translocation, in contrast to its parental “wild-type”
CHIKV replicon (Fig. 6D). This observation suggests that
SINV and CHIKV most likely employ similar mechanisms of
blocking the JAK-STAT pathway and that the conserved pro-
line in nsP2 at positions 726 and 718, respectively, is essential
for this activity.
DISCUSSION
The IFN response is the first line of defense against invading
pathogens, and therefore it is no surprise that many viruses
actively suppress this antiviral mechanism to promote virus
replication and spread (reviewed by Randall and Goodbourn
[26]). In this research, we have shown that once established,
CHIKV replication is largely resistant to treatment with type I
and II IFNs. While IFN- has been proposed as an antiviral
FIG. 5. Inhibition of IFN--induced STAT1 nuclear translocation by individual CHIKV nsPs. (A) Schematic representation of the pCMV-
nsP1, -2, -3, and -4 expression plasmids and the CHIKrep-mCherry replicon, expressing mCherry. CMV, cytomegalovirus immediate-early
promoter; 2A, foot-and-mouth disease virus 2A autoprotease. The bacteriophage SP6 and CHIKV 26S promoters are indicated. (B) pSTAT1
nuclear translocation upon IFN- induction in Vero cells transfected with pCMV-nsP1, -2, -3, or -4. Cells were immunostained with an
anti-pSTAT1 antibody. (C) pSTAT1 nuclear translocation upon IFN- induction in CHIKrep-mCherry-transfected Vero cells. Open arrowheads
indicate cells positive for nsP1, -2, -3, or -4- or for the CHIKV replicon that lack nuclear pSTAT1; solid arrowheads indicate nsP1- to nsP4-positive
cells with nuclear pSTAT1.
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drug to control CHIKV replication (36), our results suggest
that IFN may have limited use in antiviral therapy. Recent
experiments with mice support this view, showing that IFN-
treatment before, but not after, CHIKV infection inhibits disease
and viremia (12). Next, we demonstrated that CHIKV infection
and CHIKV replicon RNA replication both efficiently blocked
IFN-induced JAK-STAT signaling. This activity was mapped to
the nsP2 gene by the expression of nsP2 alone and in the context
of an attenuated CHIKV replicon harboring an nsP2 mutation
from a conserved proline to a serine at position 718.
nsP2 had earlier been recognized as an important player in
modulating the IFN response associated with host shutoff (10).
Recently, it has become clear that host shutoff and suppression
of the IFN response by alphaviruses can be regarded as sepa-
rate activities (35). In Old World alphaviruses, nsP2 has been
found to be the most important viral protein in modulating the
IFN response, with an additional role for the capsid protein in
the New World alphaviruses (1, 13). Through the generation of
adaptive mutants, nsP2 has been identified as the main viral
factor to establish persistent replication in mammalian cells.
Noncytopathic variants of SINV and Semliki Forest virus with
different mutations in nsP2 display severe defects in counter-
acting the IFN response (3, 11) and result in high IFN pro-
duction. This leads to the hypothesis that nsP2 has an essential
role in the modulation of the IFN response, likely via interfer-
ence with downstream JAK-STAT signaling. We show here for
the first time that alphavirus nsP2 alone is able to block the
JAK-STAT pathway.
Whether or not the other nsPs or their intermediate precur-
sors could possibly contribute to the activity displayed by nsP2
was not further investigated. However, given the potency of the
individual protein nsP2 in blocking STAT1 nuclear transloca-
tion, any contributory activity by other viral proteins may not
be required to establish a productive infection. Selection of
FIG. 6. Mutation of a conserved proline in nsP2 abolishes the inhibitory effect of CHIKV and SINV replicons on JAK-STAT signaling.
(A) Schematic representation of the CHIKrep-pac2AEGFP and SINrepLuc replicons. nsP2 mutations P718S and P726S are indicated with
asterisks; pac, puromycin acetyltransferase. (B) Partial amino acid alignment of alphavirus nsP2s. RRV, Ross River virus; VEEV, Venezuelan
equine encephalitis virus. The conserved proline and amino acid numbers within nsP2 proteins are indicated. (C) pSTAT1 nuclear translocation
upon IFN- induction in SINrepGFP (wild type and mutant nsP2-P726S)-transfected Vero cells. Cells were immunostained with an anti-pSTAT1
antibody. Open arrowheads indicate replicon-positive cells lacking nuclear pSTAT1; solid arrowheads indicate replicon-positive cells with nuclear
pSTAT1. (D) Nuclear translocation of phospho-STAT1 upon IFN- induction in CHIKrep-pac2AEGFP (wild type and mutant nsP2-P718S)-
transfected Vero cells. Cells were immunostained with an anti-pSTAT1 antibody.
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Vero or BHK-21J cell lines harboring persistently replicating,
attenuated CHIKV replicon RNA was unfortunately not ac-
complished. It might be possible that for CHIKV replicons,
additional mutations in nsP2 or other locations are required to
support persistent replication in mammalian cells, as was pre-
viously reported for noncytopathic SINV (8).
Previous research has suggested important roles for nsP2
and a host-encoded cellular endoribonuclease, RNase L, in
initiating the transition from minus- to plus-strand RNA syn-
thesis (30, 34). Since RNase L is activated by OAS, which itself
is an interferon-stimulated gene (ISG), this seems at odds with
the inhibitory role of nsP2 on the JAK/STAT pathway. How-
ever, the switch from the minus-strand replication complex
(RC) to RC
 occurs at a later stage during infection, and
only after cleavage of the nsP2/3 precursor. In CHIKV-in-
fected cells, we have observed inhibition of OAS induction by
IFN treatment at later time points (	8 hpi). This correlates
with the current view that nsP2 is released in its free form after
early replication has been established and creates an environ-
ment where host transcription/translation is reduced and the
IFN response is actively suppressed.
We have shown by several different experimental ap-
proaches that CHIKV replication blocks the JAK-STAT path-
way, yet the exact mechanism at the molecular level remains to
be elucidated in follow-up experiments. We have ruled out the
possibility that the observed blockage of JAK-STAT signaling
was due to host shutoff, since signaling in these settings was
unaffected in cells treated with cycloheximide. We have also
ruled out the possibility that CHIKV reduces endogenous
STAT1 levels, similar to what was reported for VEEV- and
SINV-infected cells (41).
During dengue virus infection, STAT1 nuclear translocation
is inhibited by dengue virus nonstructural protein NS5 as an
indirect result of the prevention of STAT2 phosphorylation
and STAT1-STAT2 heterodimer formation (2, 23). Conse-
quently, dengue virus is not capable of inhibiting IFN--in-
duced STAT1 phosphorylation/homodimer formation. In con-
trast to dengue virus, however, incubation with IFN- of cells
infected with CHIKV or transfected with a CHIKV replicon
demonstrates that STAT1 activation is blocked (Fig. 3C and
4C), suggesting that the inhibitory mechanism is different in
the case of CHIKV.
The increased STAT1 levels upon IFN induction in normal
but not in CHIKV-infected cells (Fig. 3D) may be the result of
signal transduction via the JAK-STAT pathway, as was sug-
gested earlier (22). In this scenario, STAT1 upregulation in
CHIKV-infected cells is prevented by active inhibition of JAK-
STAT signaling, which is supported by the observed decreased
luciferase production from the IFN-responsive plasmids in in-
fected cells (Fig. 2).
We showed that a SINV replicon containing nsP2 with a
serine at position 726 was not able to efficiently block phospho-
STAT1 nuclear translocation, in contrast to the “wild-type”
SINV replicon containing nsP2 with a restored proline at po-
sition 726. Others have previously claimed that wild-type SINV
infection does not impair the ability to respond to IFN-, as
judged by similar levels of STAT1 phosphorylation in infected
and uninfected cells (20). The reason for this apparent discrep-
ancy in results is not clear, but an explanation may be the
timing of the experiment or the genetic background of the
SINV constructs. In our studies, we induced Vero cells with
IFN 24 h after transfection with a pToto1101-derived replicon
(28), whereas Lin et al. (20) used a dsTE12Q recombinant
Sindbis virus vector (19) and induced Vero cells with IFN 6 h
p.i. It would be interesting to map the putative differences
between these SINV vectors, within nsP2 or elsewhere in the
genome, and to identify the domain(s) or amino acid(s) re-
sponsible.
Taken together, the inability of alphaviruses with mutated
nsP2 proteins to efficiently block STAT1 nuclear translocation
may now provide an explanation for the reported overall in-
creased IFN production by such mutants. In this light, it is
noteworthy that in preliminary studies, Ross River virus
(RRV), another arthrogenic alphavirus and a close relative of
CHIKV, does not appear to antagonize STAT1 activation (6),
although this finding awaits confirmation. In future research, it
may be interesting to investigate whether this apparent differ-
ence between CHIKV and RRV could be due to differences of
their respective nsP2 proteins. Mapping the functional do-
mains within CHIKV nsP2 and deciphering the exact mecha-
nism by which nsP2 blocks the JAK-STAT pathway, possibly by
preventing STAT1 phosphorylation and/or prohibiting the nu-
clear import of phosphorylated STAT1, will be the focus of
future studies in our laboratories. Our results may also provide
insights into the development of live-attenuated vaccines to
control CHIKV and other alphavirus infections.
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